Hite Jinro (000080.KS) stock: key figures, P/E, revenue and dividend
Consumer Staples · Distillers & Vintners · South Korea · ISIN KR7000080002
Price
16,480.00 KRW
Market cap
1.15 tn KRW
P/E (2025)
27.72
P/S (2025)
0.46
Dividend yield
0.00 %
Net margin
1.66 %
Return on equity (ROE)
3.70 %
Return on assets (ROA)
1.27 %
Hite Jinro financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.60 tn KRW | 2.50 tn KRW |
| Gross profit | 1.19 tn KRW | 1.11 tn KRW |
| Operating income | 208.14 bn KRW | 172.34 bn KRW |
| EBIT | 181.39 bn KRW | 112.65 bn KRW |
| Net income | 95.87 bn KRW | 41.49 bn KRW |
| Diluted EPS – continuing operations | 1,396.47 KRW | 594.59 KRW |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hite Jinro
HITEJINRO Co., Ltd. manufactures and sells alcoholic beverages in South Korea. It provides beer, soju, bottled water, and other products. The company was formerly known as Jinro Ltd and changed its name to HITEJINRO Co., Ltd. in September 2011. HITEJINRO Co., Ltd. is headquartered in Seoul, South Korea.
More stocks
- KRONOS WORLDWIDE INC (KRO)
- Caisse Regionale De Credit Agricole Mutuel Sud Rhone Alpes (CRSU.PA)
- GR Engineering Services Ltd (GNG.AX)
- Borr Drilling Ltd (BORR)
- MedCap AB (publ) (MCAP.ST)
- Hygeia Healthcare Holdings Co Ltd (6078.HK)
- N-able, Inc. (NABL)
- Zhongtong Bus Holding Co Ltd (000957.SZ)
- Obsidian Therapeutics, Inc. Common Stock (OBX)
- Beta Bionics, Inc. (BBNX)
- Synsam AB (publ) (SYNSAM.ST)
- Zhejiang Tongxing Technology Co. Ltd. A (301252.SZ)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.